Global Influenza Diagnostics Market- Market Overview:

The global influenza diagnostics market is expected to grow from USD 1.6 billion in 2022 to USD 2.58 billion by 2030, at a CAGR of 6.2% during the Projection period 2023-2030. The growth of this market is mainly driven owing to the rising cases of influenza globally.

Human disease is caused by three types of influenza, due to its high susceptibility to antigenic variation, and is primarily caused by influenza A. Influenza is a severe viral respiratory infection that causes significant morbidity and mortality worldwide. The most common type of influenza is influenza A, which causes pandemics. Influenza symptoms include fever, cough, chills or sweats, myalgias, and malaise and is highly contagious. Advances in molecular and biomedical technologies have led to a wide range of influenza diagnostic and monitoring methods. These new genomic and proteomic detection methods have led to the discovery of new influenza viruses. With the advancement of molecular and biomedical technologies and the human genome project, new assays and technologies have become available to diagnose and manage influenza infections. Medical professionals and patients can make various important medical decisions in terms of care and support if influenza is diagnosed early. Early diagnosis leads to better treatment and future care, and leads to better treatment and future care. An accurate and early diagnosis can be obtained by observing a number of cognitive symptoms related to a specific medical condition. The laboratory examination is one of the most popular and effective testing techniques used to detect the disease.

Sample Request: - Global Influenza Diagnostics Market

Market Dynamics:

Drivers:                          

• Proteomics and genomic technology advancements

A variety of assays and technologies have been developed for diagnosing and managing influenza infections based on the human genome project and advances in molecular and biomedical technologies. As a result of these new technologies, which are derived from genomics and proteomics, new influenza viruses are discovered. Infectious diseases can also be better monitored and diagnosed quickly, creating market opportunities.

Restraints:                                             

• Lack of skilled professionals

The market growth is hampered mainly due to lack of unskilled professionals. It has been observed that the detection tests performed by the professional who don’t have hand-on-experience on the detection kits and devices leads to false results sometimes which affects the patients trust on these detection kits, which is ultimately impacting the growth of the market negatively.

Opportunities:

• Rising research and development activities

By providing technologically sophisticated solutions to identify influenza, the increased R&D spending will boost global adoption rates of these diagnostic tests. In the upcoming years, the market revenue for quick influenza diagnostic testing will rise due to the widespread use of quick influenza diagnostic testing and the rising influenza prevalence.

Challenges:

• Unstable regulatory framework

The market is witnessing immense growth but the instability in regulatory framework is creating various challenges in the growth of the market. Delay in reimbursement and approval for the tests is hampering the market growth. Moreover, antigenic variations of influenza viruses are arising complexities in the final result which is affecting the market growth.

Segmentation Analysis:

The global influenza diagnostics market has been segmented based on test type, end-user, and region.

By Test Type

The test type segment includes cell culture, RIDT, RT-PCR and others. The RIDT segment led the largest share of the influenza diagnostics market with a market share of around 32% in 2022. In rapid influenza diagnostic tests (RIDTs), viral nucleoprotein antigens can be detected and the results can either be interpreted as positive or negative. As the influenza diagnostics market grows at the fastest rate over the Projection period, rapid influenza diagnostic tests (RIDTs) are expected to hold the majority of revenue share. Influenza diagnostic testing has become more common in clinical settings for surveillance and patient management. A number of RIDTs can be used at home and in the office, and can also be used at the point of care by CLIA.

By End-User

The end-user segment includes diagnostic laboratories, clinics, hospitals and others. The hospital’s segment led the largest share of the influenza diagnostics market with a market share of around 32% in 2022. Increasing numbers of influenza patients have resulted in the use of flu diagnostics in hospitals for their detection of influenza viruses. Hospitals have advanced and highly sophisticated equipment, which can detect influenza viruses accurately and efficiently. In hospitals, there is an increasing demand for advanced influenza diagnostic kits and instruments due to the increasing number of hospitalizations during active influenza seasons and rising healthcare expenditures.

Global Influenza Diagnostics Market- Sales Analysis.

The sale of influenza diagnostics expanded at a CAGR of 5.8% from 2016 to 2022.

In order to increase the market for influenza diagnostics, organizations are taking initiatives to promote early diagnosis practices in order to prevent and eradicate mortality caused by the disease. Increasing awareness among the global population regarding the importance of early disease detection is one of the major factors driving its growth.

Market growth will be complemented by government initiatives to counter flu and develop accurate tests. As a result of technical requirements and regulatory processes for high or moderate tests, the influenza diagnostics market may experience a slowdown during the Projection period. The majority of research activity is directed towards developing faster and more accurate diagnostic solutions for influenza viruses, which will lead to market growth.

Thus, owing to the aforementioned factors, the global influenza diagnostics market is expected to grow at a CAGR of 6.2% during the Projection period from 2023 to 2030.

By Regional Analysis:

The regions analyzed for the influenza diagnostics market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North American region dominated the influenza diagnostics market and held a 37.9% share of the market revenue in 2022.

• The North American region witnessed a major share. Market growth is expected to be positively affected in the coming years by the rising disease burden. There is wide availability of RIDTs in the region. RIDTs are widely available because they produce results in 15 minutes, so they are more widely available. With the rise in influenza-related hospitalizations and pediatric deaths, RIDTs can be used to generate results as quickly as 15 minutes. Several factors are expected to drive the growth of the North American influenza diagnostics market in the coming years, including government organizations' desire to manage the disease in a proper way.
• Asia Pacific is anticipated to experience significant growth during the predicted period. As a result of an increasing number of influenza incidences, an ageing population, increased focus of key vendors on this region, favourable reimbursement scenario for diagnostic procedures, increasing government investments in support of the healthcare sector, improved infrastructure and accessibility to healthcare, and an increasing demand for higher quality healthcare, the Asia-Pacific region is Projection to grow at the fastest CAGR during the Projection period.

Global Influenza Diagnostics Market - Country Analysis:

• Germany

Germany's influenza diagnostics market size was valued at USD 0.10 billion in 2022 and is expected to reach USD 0.16 billion by 2030, at a CAGR of 6.3% from 2023 to 2030.

A number of factors are contributing to the dominance of Germany in the regional market for rapid influenza diagnostic tests, including an increase in influenza prevalence, supportive government interventions, the presence of influential leaders, and advanced facilities throughout the country. Furthermore, manufacturing facilities improve the country's access to influenza testing kits.

• China

China’s influenza diagnostics market size was valued at USD 0.11 billion in 2022 and is expected to reach USD 0.18 billion by 2030, at a CAGR of 6.5% from 2023 to 2030.

China's influenza diagnostics market is projected to grow over the Projection period due to technological advancements that facilitate the development of advanced diagnostic devices. A lack of flu-positive samples, a lack of representatives to collect samples, and difficulty shipping the samples are the most common challenges experienced by the country.

• India

India's influenza diagnostics market size was valued at USD 0.09 billion in 2022 and is expected to reach USD 0.14 billion by 2030, at a CAGR of 6.4% from 2023 to 2030.

New and developed technologies, awareness among the people, a high population density, and substantial growth in disease burden are the major factors in the country. Moreover, major players in the influenza diagnostics industry are adopting various strategies to maximize revenue, such as R&D investment, the use of advanced techniques, and the launch of new products.

Key Industry Players Analysis:  

To increase their market position in the global influenza diagnostics market business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.

• Hologic, Inc.
• Hoffmann-LA Roche AG
• Thermo Fisher Scientific, Inc.
• Quidel Corporation
• Abbott Laboratories, Inc.
• Becton, Dickson and Company
• 3M
• Sekisui Diagnostics
• SA Scientific
• Meridian Bioscience, Inc.

Latest Development:

• In February 2022, As part of its collaboration with the United Nations Children's Fund, Siemens Healthineers today announced its commitment to improving access to diagnostics and treatment in various African regions.
• In May 2022, An American pharmaceutical company received FDA approval for Aptima CMV Quant Assay, an extremely valuable tool for reducing the negative effects of human cytomegalovirus.

Report Metrics

Report Attribute	Details
Study Period	2022-2030
Base year	2022
CAGR (%)	6.2%
Market Size	1.6 billion in 2022
Projection period	2023-2030
Projection unit	Value (USD)
Segments covered	By Test Type, By End-User, and By Region.
Report Scope	Revenue Projection, competitive landscape, company ranking, growth factors, and trends
Companies covered	Hologic, Inc., F. Hoffmann-LA Roche AG, Thermo Fisher Scientific, Inc., Quidel Corporation, Abbott Laboratories, Inc., Becton, Dickson and Company, 3M, Sekisui Diagnostics, SA Scientific, and Meridian Bioscience, Inc.
By Test Type	Cell Culture RIDT RT-PCR Others
By End-User	Diagnostic Laboratories Clinics Hospitals Others
Regional scope	North America Europe Asia-Pacific South America Middle East and Africa

Scope of the Report

Global Influenza Diagnostics Market by Test Type:

• Cell Culture
• RIDT
• RT-PCR
• Others

Global Influenza Diagnostics Market by End-User:

• Diagnostic Laboratories
• Clinics
• Hospitals
• Others

Global Influenza Diagnostics Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
• Asia-Pacific
  • Japan
  • China
  • India
  • Korea
  • Southeast Asia
• South America
  • Brazil
  • Peru
• Middle East and Africa
  • UAE
  • South Africa
  • Saudi Arabia

Political Factors- The influenza diagnostics market was impacted by the country's recent level of political stability. Furthermore, high-ranking government officials may be forced to resign or be impeached due to the honesty of the politicians and their propensity to commit crimes of corruption. the laws that the country enforces, especially those that deal with business, like contract law, because they outline what is and isn't allowed to be done. For instance, some countries prohibit alcohol or have strict regulations that must be followed, while other governments have bloated bureaucracies that discourage business.

Economic Factors- Whether the market is now organised as a monopoly, oligopoly, or anything more akin to a system of perfect competition. Depending on the country's GDP growth rate, will likely expand in the near future at a varying pace. The amount that people are willing to invest and borrow is influenced by the country's interest rates. Higher rates would encourage greater investment, which would boost GDP. The country's exchange rate would have an effect on profitability, particularly if it engaged in international trade.

Social Factors- The population's age and gender distribution significantly affects whether or not a certain product may be marketed to them. Because makeup is predominantly marketed to women, targeting a demographic that is mostly male would result in fewer people being reached than targeting a group that is mostly female. It would be hard to promote a premium product to the broader public if the majority of individuals belonged to a lower class; instead, they would have to concentrate on extremely specialised niche markets. Therefore, the distribution of classes throughout the population is vital. Due to the differences in the educational backgrounds of marketers and the target market, it could be difficult to effectively relate to and draw in the target market.

Technological Factors- opponents' aforementioned technological developments and breakthroughs. The degree of adoption of a new technology, as well as how quickly it is developing and displacing sales from competitors in the business in question, must all be closely monitored. This would be the level of urgency required to effectively react to the creation, either by matching the technology or developing a unique replacement. How quickly will the technology be adopted by additional companies in the market, leading them to copy its technological features or procedures? How much the fundamental characteristics of the product might change or advance as technology develops? If this improvement is drastic, other companies in the industry will be more negatively impacted.

Environmental Factors-  The ability to move materials and the finished product may be significantly impacted by the weather at this time. In the event of an unexpected monsoon, this would then affect when the finished product would be delivered. Climate change would cause some goods to lose all of their value. In the case of textiles, warm winter gear has a substantially smaller market in countries where the winter has become quite mild as a result of global warming. Businesses with high rubbish production may face legal restrictions on their environmental practises.

Legal Factors- As was already stated, the goal of intellectual property laws and other data protection legislation is to protect the ideas and patents of companies who solely profit from the information. The system will lose its competitive edge and is very likely to fail if there is a risk of data theft. Anti-discrimination rules passed by the government are meant to protect employees and ensure that everyone is treated fairly and given the same opportunities, regardless of gender, age, handicap, race, religion, or sexual orientation. Health and safety laws were formed as a result of witnessing the horrifying conditions that people had to work in during and immediately after the industrial revolution.

1. Introduction
   • 1. Objectives of the Study
   • 2. Market Definition
   • 3. Research Scope
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
   • 1. Porter’s Five Forces Analysis
   • 2. Value Chain Analysis
   • 3. Top Investment Pockets
     • 3.1. Market Attractiveness Analysis By Test Type
     • 3.2. Market Attractiveness Analysis By End-User
     • 3.3. Market Attractiveness Analysis By Region
   • 4. Industry Trends
5. Market Dynamics
   • 1. Market Evaluation
   • 2. Drivers
     • 2.1. Proteomics and genomic technology advancements
   • 3. Restraints
     • 3.1. Lack of skilled professionals
   • 4. Opportunities
     • 4.1. Rising research and development activities
   • 5. Challenges
     • 5.1. Unstable regulatory framework

6. Global Influenza Diagnostics Market Analysis and Projection, By Test Type
   • 1. Segment Overview
   • 2. Cell Culture
   • 3. RIDT
   • 4. RT-PCR
   • 5. Others
7. Global Influenza Diagnostics Market Analysis and Projection, By End-User
   • 1. Segment Overview
   • 2. Diagnostic Laboratories
   • 3. Clinics
   • 4. Hospitals
   • 5. Others
8. Global Influenza Diagnostics Market Analysis and Projection, By Regional Analysis
   • 1. Segment Overview
   • 2. North America
     • 2.1. U.S.
     • 2.2. Canada
     • 2.3. Mexico
   • 3. Europe
     • 3.1. Germany
     • 3.2. France
     • 3.3. U.K.
     • 3.4. Italy
     • 3.5. Spain
   • 4. Asia-Pacific
     • 4.1. Japan
     • 4.2. China
     • 4.3. India
   • 5. South America
     • 5.1. Brazil
   • 6. Middle East and Africa
     • 6.1. UAE
     • 6.2. South Africa

9. Global Influenza Diagnostics Market-Competitive Landscape
   • 1. Overview
   • 2. Market Share of Key Players in the Influenza Diagnostics Market
     • 2.1. Global Company Market Share
     • 2.2. North America Company Market Share
     • 2.3. Europe Company Market Share
     • 2.4. APAC Company Market Share
   • 3. Competitive Situations and Trends
     • 3.1. Technology Launches and Developments
     • 3.2. Partnerships, Collaborations, and Agreements
     • 3.3. Mergers & Acquisitions
     • 3.4. Expansions

10. Company Profiles
    • Hologic, Inc.
      • 1.1. Business Overview
      • 1.2. Company Snapshot
      • 1.3. Company Market Share Analysis
      • 1.4. Company Technology Portfolio
      • 1.5. Recent Developments
      • 1.6. SWOT Analysis
    • Hoffmann-LA Roche AG
      • 2.1. Business Overview
      • 2.2. Company Snapshot
      • 2.3. Company Market Share Analysis
      • 2.4. Company Technology Portfolio
      • 2.5. Recent Developments
      • 2.6. SWOT Analysis
    • Thermo Fisher Scientific, Inc.
      • 3.1. Business Overview
      • 3.2. Company Snapshot
      • 3.3. Company Market Share Analysis
      • 3.4. Company Technology Portfolio
      • 3.5. Recent Developments
      • 3.6. SWOT Analysis
    • Quidel Corporation
      • 4.1. Business Overview
      • 4.2. Company Snapshot
      • 4.3. Company Market Share Analysis
      • 4.4. Company Technology Portfolio
      • 4.5. Recent Developments
      • 4.6. SWOT Analysis
    • Abbott Laboratories, Inc.
      • 5.1. Business Overview
      • 5.2. Company Snapshot
      • 5.3. Company Market Share Analysis
      • 5.4. Company Technology Portfolio
      • 5.5. Recent Developments
      • 5.6. SWOT Analysis
    • Becton, Dickson and Company
      • 6.1. Business Overview
      • 6.2. Company Snapshot
      • 6.3. Company Market Share Analysis
      • 6.4. Company Technology Portfolio
      • 6.5. Recent Developments
      • 6.6. SWOT Analysis
    • 3M
      • 7.1. Business Overview
      • 7.2. Company Snapshot
      • 7.3. Company Market Share Analysis
      • 7.4. Company Technology Portfolio
      • 7.5. Recent Developments
      • 7.6. SWOT Analysis
    • Sekisui Diagnostics
      • 8.1. Business Overview
      • 8.2. Company Snapshot
      • 8.3. Company Market Share Analysis
      • 8.4. Company Technology Portfolio
      • 8.5. Recent Developments
      • 8.6. SWOT Analysis
    • SA Scientific
      • 9.1. Business Overview
      • 9.2. Company Snapshot
      • 9.3. Company Market Share Analysis
      • 9.4. Company Technology Portfolio
      • 9.5. Recent Developments
      • 9.6. SWOT Analysis
    • Meridian Bioscience, Inc.
      • Business Overview
      • Company Snapshot
      • Company Market Share Analysis
      • Company Technology Portfolio
      • Recent Developments
      • SWOT Analysis

List of Table

1. Global Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
2. Global Cell Culture, Influenza Diagnostics Market, By Region, 2023–2030 (USD Billion)
3. Global RIDT, Influenza Diagnostics Market, By Region, 2023–2030 (USD Billion)
4. Global RT-PCR, Influenza Diagnostics Market, By Region, 2023–2030 (USD Billion)
5. Global Others, Influenza Diagnostics Market, By Region, 2023–2030 (USD Billion)
6. Global Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
7. Global Diagnostic Laboratories, Influenza Diagnostics Market, By Region, 2023–2030 (USD Billion)
8. Global Clinics, Influenza Diagnostics Market, By Region, 2023–2030 (USD Billion)
9. Global Hospitals, Influenza Diagnostics Market, By Region, 2023–2030 (USD Billion)
10. Global Others, Influenza Diagnostics Market, By Region, 2023–2030 (USD Billion)
11. Global Influenza Diagnostics Market, By Region, 2023–2030 (USD Billion)
12. North America Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
13. North America Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
14. USA Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
15. USA Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)  
16. Canada Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
17. Canada Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
18. Mexico Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
19. Mexico Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
20. Europe Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
21. Europe Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
22. Germany Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
23. Germany Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
24. France Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
25. France Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
26. UK Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
27. UK Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
28. Italy Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
29. Italy Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
30. Spain Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
31. Spain Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
32. Asia Pacific Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
33. Asia Pacific Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
34. Japan Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
35. Japan Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
36. China Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
37. China Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
38. India Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
39. India Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
40. South America Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
41. South America Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
42. Brazil Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
43. Brazil Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
44. Middle East and Africa Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
45. Middle East and Africa Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
46. UAE Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
47. UAE Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)
48. South Africa Influenza Diagnostics Market, By Test Type, 2023–2030 (USD Billion)
49. South Africa Influenza Diagnostics Market, By End-User 2023–2030 (USD Billion)

List of Figures 

1. Global Influenza Diagnostics Market Segmentation
2. Influenza Diagnostics Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Influenza Diagnostics Market Attractiveness Analysis By Test Type
9. Global Influenza Diagnostics Market Attractiveness Analysis By End-User
10. Global Influenza Diagnostics Market Attractiveness Analysis By Region
11. Global Influenza Diagnostics Market: Dynamics
12. Global Influenza Diagnostics Market Share By Test Type (2023 & 2030)
13. Global Influenza Diagnostics Market Share By End-User (2023 & 2030)
14. Global Influenza Diagnostics Market Share by Regions (2023 & 2030)
15. Global Influenza Diagnostics Market Share by Company (2021)